The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing ( discussing the 340B program and its growth and impacts on patients.

Discount drug program requires drug companies to sell deeply discounted drugs to hospitals that serve high numbers of ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...